In November 2020 it was announced that Absorption System had been acquired by Pharmaron Holdings on behalf of Pharmaron Beijing Co Ltd. With facilities also in San Diego and Japan, Absorption Systems, LP (ASLP) had focused on performing assays that can predict the Absorption, Distribution, Metabolism, and Excretion (ADME) of small molecules using a variety of in vitro, in situ, and in vivo models. ASLP supports these assays with state of the art bioanalytical capabilities and preclinical formulation services. Absorption Systems, is focused to testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity) and medical devices for efficacy and safety. Absorption Systems assists pharmaceutical and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) barriers in the development of drugs and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. The CellPort Technologies® platform, a suite of human cell-based test systems for drug transporter characterization, exemplifies Absorption Systems' commitment to innovation and is soon to be an industry assay standard for in vitro drug interaction assessmen
